Background No study has evaluated current scoring systems for their accuracy in predicting short and long-term outcome of alcoholic hepatitis in a US population. Methods We reviewed electronic records for patients with alcoholic liver disease (ALD) admitted to Parkland Memorial Hospital between January 2002 and August 2005. Data and outcomes for 148 of 1,761 admissions meeting pre-defined criteria were collected. The discriminant function (DF) was revised (INRdf) to account for changes in prothrombin time reagents that could potentially affect identification of risk using the previous DF threshold of[32. Admission and theoretical peak scores were calculated by use of the Model for End-stage Liver Disease (MELD). Analysis models compared five different scoring systems. Results INRdf was closely correlated with the old DF (r 2 = 0.95). Multivariate analysis of the data showed that survival for 28 days was significantly associated with a scoring system using a combination of age, bilirubin, coagulation status, and creatinine (p \ 0.001), and an elevated ammonia result within two days of admission (p = 0.012).
Introduction
Management of severe alcoholic hepatitis is not uniform in the US despite decades of clinical research [1] [2] [3] . The value of corticosteroid therapy for a sub-group of patients has often been debated [4] [5] [6] . In 2008, the Cochrane Hepato-Biliary Group systematic review, with meta-analyses and trial sequential analyses, concluded that the current evidence base did not support the use of corticosteroids and that additional data were needed [7] , although the guidelines of gastroenterology and hepatology societies advocate corticosteroids for more severe disease [8] .
Factors that may affect short (28 day) or intermediateterm (90 day or 6 month) survival in alcoholic hepatitis now include geographic location and availability of orthotopic liver transplantation. Limitations on transplantation arise from either lack of eligibility, i.e. lack of documentary evidence of complete abstinence for six months, or lack of financial resources, or both. Identifying those likely to benefit from corticosteroids or alternative novel therapy in the short-term may be important for understanding not only intermediate but also long-term ([12 months) survival with or without rescue transplantation.
The criteria for defining steroid-responsive severe disease were originally established by Maddrey et al. [9] . The equation that discriminated patients with the potential to benefit from corticosteroid therapy is often termed the Maddrey discriminant function (DF). The equation was a simple calculation based on total bilirubin and prothrombin time [9] which was then modified by Carithers et al. [10] so that prothrombin time (PT) measurements in different institutions could be compared and combined in clinical trials.
Since the empiric generation of the Maddrey DF in the 1970s, measurements of total bilirubin have not changed. In contrast, measurement of the PT has undergone a series of improvements, designed to enable comparison of results between different laboratories [11] [12] [13] . New scoring systems to assess the severity of alcoholic hepatitis, with measures other than PT to assess coagulopathy, were developed in Scotland [14] and Spain [15] and compared with DF and the Model for End-stage Liver Disease (MELD) score for European [16] [17] [18] and Mexican [19] patients. We postulated that changes in PT reagents altered the DF threshold in a quantifiable manner. This retrospective cross-sectional study was undertaken to examine this hypothesis and, by using five different scoring systems, to identify factors that predicted survival of US patients. 
Materials and Methods

A UT
Patient Selection Criteria
Inclusion criteria were based on laboratory features consistent with jaundice from an acute decompensation in ALD (bilirubin [ 5 mg/dL unaccounted for by another etiology or transfusion, AST increased and \500 U/L with AST [ ALT). Results from a clinical data repository were extracted; radiology, pathology, and discharge summaries were reviewed for relevant information. Exclusion criteria were concomitant liver disease, persistent hyperbilirubinemia for [2 months prior to admission, abstinence confirmed on multiple encounters, an alternative diagnosis, or a previous index admission. Results of paracentesis in the first two days of the admission were used as a surrogate marker of clinical ascites and any elevated ammonia level in the first two days was used as a marker of deteriorated overall liver function. This time period enabled improvement or deterioration of patients when initially hospitalized, a strategy comparable with the observation period before use of corticosteroids for management.
PT Measurements
Conversion of PT measured in seconds to International Normalized Ratio (INR) is dependent on the patient's PT, the reference PT, and the international sensitivity index (ISI) of the manufacturer's reagents. The equation is INR = (patient PT/geometric mean of reference interval PT) ISI . The geometric mean reference interval changed from 10.69 (July-October 1997) to 11.13 (November 1997-November 1998) and then to 11.71 (since December 1998). The ISI changed in December 1998 from 1.5 to 1.0. We calculated the effect on the PT of these changes in reagent sensitivity (ISI) and reference interval. 
Data Collection and Analysis
Demographics and laboratory test results were collected for all patients and entered into a computerized database. The Maddrey DF as modified for multi-site studies [10] , an INR-based discriminant function (INRdf), MELD score with United Network for Organ Sharing modification [20] , the Glasgow alcoholic hepatitis score (GAHS) [14] , and the age ? serum bilirubin ? INR ? serum creatinine (ABIC) score [15] were calculated at admission. Peak bilirubin, PT, INR, and creatinine levels were recorded and a theoretical peak MELD score was calculated from these data. The equations used for calculation of DF, INRdf, MELD, and ABIC scores, and GAHS are given in supplementary Table A .
Statistical Analysis
Comparisons of demographics, laboratory values and mortality were performed among INRdf groups. Continuous variables were compared by use of Student's t test, Wilcoxon rank-sum (Mann-Whitney) tests, or Spearman's rank correlation; categorical variables were compared by use of chi-squared tests or Fisher's exact tests. Patient survival was estimated by use of the Kaplan-Meier method. Log-rank tests were conducted to examine whether survival was significantly different among groups. A univariate Cox proportional hazards model was used to examine the association between risk factors and survival. Risk factors with a p value less than 0.05 from univariate Cox regression were entered as candidate risk factors in a stepwise Cox proportional hazards model, which was used to identify significant factors associated with survival. Variables were automatically excluded from multivariate analysis for collinearity. Statistical analysis was performed with Stata 12.1 (College Station, TX, USA) and SAS 9.3 (SAS Institute, Cary, NC, USA).
Results
We reviewed the electronic charts of all patients with diagnosis of acute alcoholic hepatitis, alcoholic cirrhosis, or alcoholic liver disease not otherwise specified (ICD-9 571.1, 571.2 or 571.3) admitted to PMH between January 2002 and August 2005 (Fig. 1) . A total of 148 patients met the criteria for an index admission. Admissions for these 148 patients accounted for 9 % (154/1,761) of total hospitalizations with a diagnosis of alcoholic liver disease. Maximum bilirubin \5 mg/dL was the commonest reason for exclusion followed by AST not matching entry criteria. AST was normal for 329 admissions (bilirubin was also normal for 50, no recent alcohol for 21), ALT exceeded AST (n = 63), and AST [ 500 IU/L (n = 57) were the findings. On the basis of calculation of INRdf on admission, patients were classified into two mutually exclusive groups ( Fig. 1 ; Table 1 ).
Demographic and Initial Clinical Characteristics
As shown in Table 1 , patients with INRdf \50 (n = 115, 78 %) had less severe alcoholic hepatitis with MELD scores of 22 ± 5 (mean ± SD) and DF \ 32 for 59 %. Patients with INRdf [50 had more severe disease with initial MELD scores 32 ± 6 (n = 33, 22 %); all of these patients had a DF [ 32 and MELD [ 21. The two groups were similar with regard to gender and ethnicity (Table 1) ; Fig. 1 Overall flow chart. Diagnoses resulting in exclusion, other than chronic hepatitis C and hepatocellular carcinoma, included acute and chronic hepatitis B, acute cholecystitis, acute kidney injury in an incarcerated patient, cholangiocarcinoma, chronic kidney disease with cirrhosis, cocaine ischemic liver injury, common bile duct transection, congestive heart failure, empyema of gall bladder, gas gangrene, hematoma, hemophagocytic histoplasmosis, incarcerated para-umbilical hernia, metastatic liver disease, motor vehicle accident, non-alcoholic fatty liver disease, pancreatitis, post-operative decompensation, primary biliary cirrhosis, renal cell carcinoma, secondary peritonitis, sepsis, Stevens-Johnson syndrome, subarachnoid hemorrhage, subdural hematoma, and suspected drug-induced liver injury
INRdf [50 patients were younger, this was not statistically significant (p = 0.054).
The calculated DF, ABIC, and MELD scores and GAHS were significantly different between the groups, reflecting the contribution of bilirubin and INR to the calculations (Table 1) Table B ). Elevated ammonia within the first two days of admission was statistically more common among patients with more severe disease (p = 0.016).
Hospitalization Follow-Up
Most of the patients developed worsening liver function during the index admission; bilirubin increased for 50 %, PT for 51 %, and INR for 41 % (supplementary Table B ). The significant differences between the INRdf groups on admission persisted when peak values were compared. Renal function deteriorated for a subset of patients in both groups during the index hospitalization; overall creatinine increased for 56 % of subjects, with higher frequency among those with more severe alcoholic hepatitis (supplementary Table B ). Theoretical peak MELD scores (calculated from the highest values for each variable) increased after admission in the majority of patients (58 %). INRdf groups were statistically different when comparing peak MELD values and the distribution into MELD subgroups (\21 and [31).
Mortality
Death certificate data for all-cause mortality were obtained from Texas State Department of Health Statistics. At each time point, (28 days, 90 days, 6 months, 5 years, and overall) there were fewer survivors in the more severely affected groups (supplementary Table C admission gave similar results (40-44 % alive at 28 days) with more subjects identified by use of INRdf (15/26 untreated with corticosteroids were deceased). Using DF [ 32 for stratification was less informative (66 % alive at 28 days); the category included more subjects. The early end-points enable comparison with previous studies using 28 day or 90 day mortality to assess management strategies. When patients who received corticosteroids (n = 8) or corticosteroids and pentoxifylline (n = 1) were excluded, overall mortality was unchanged, reflecting the small number of subjects receiving specific treatments (supplementary Table C ). As expected, a peak MELD [ 31 was highly predictive of mortality with 60 % (28/47) succumbing by 28 days and
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Comparison of subjects with more severe disease on admission using different scoring systems 79 % by 90 days. Irrespective of acuteness, mortality was high for subjects with a creatinine level that rose at least 0.3 mg/dL during hospitalization (n = 48, with median peak creatinine 3.4 mg/dL, range 0.9-13.5 mg/dL); 50 % were known to be dead at 28 days and 69 % at 90 days. In contrast, mortality was relatively low for subjects with a creatinine level that rose \0.3 mg/dL during hospitalization (n = 100, with median peak creatinine 0.9 mg/dL, range 0.45-4.35 mg/dL); 7 % were known to be dead at 28 days and 19 % at 90 days (5 and 7 unknown at 28 and 90 days respectively). For either financial or psychosocial reasons, none of the cohort was eligible for orthotopic liver transplantation.
Survival Analysis
The 28-day Kaplan-Meier survival curves of the different admission stratification groups were clearly separated; admission INRdf (p \ 0.0001, chi = 36.20) and ABIC (p \ 0.0001, chi = 23.47) were of higher statistical significance than admission MELD (log-rank p = 0.0012 for MELD \ 21 and 0.0006 for MELD \ 31). DF was the
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Comparison of subjects with more severe disease on admission using different scoring systems Long-term survival was different depending on the severity of the alcoholic liver disease at the index admission as measured by INRdf, DF, ABIC, GAHS, or MELD; peak MELD stratification was also informative (Fig. 3) . The dismal prognosis for all these patients is emphasized by the short median survival of those with a known fiveyear outcome, even in the least affected groups (supplementary Table D ). Only subjects with a peak MELD \ 21 had a substantially longer median survival (65 months; supplementary Table D) . Co-existence of chronic hepatitis C and alcoholic liver disease further shortened survival (supplementary Table D) . One abstinent subject with chronic hepatitis C underwent transplantation more than 12 months after admission for icteric liver disease.
Predictive Factors
A Cox proportional hazards model was used to identify factors predicting survival for 28 days after admission (Table 2 ). In univariate analysis of continuous variables measured on admission, higher bilirubin, creatinine, INR and PT levels, WBC counts, and scoring systems other than GAHS were significantly associated with poor survival. Categorical variables measured on admission or within two days of admission (DF group, INRdf group, ABIC group, MELD group and elevated ammonia) were also significant predictors of poor survival. When later data from the index admission were analyzed, peak MELD score and peak MELD group predicted poor survival as did the difference in creatinine between admission and its peak value (Table 2) .
Stepwise Cox regression analysis identified independent predictors of 28-day survival (Table 3) . Of the ''present on admission'' variables, ABIC category and Area under receiver operating curve (ROC) à Within two days of admission hyperammonemia within two days of admission were significant. INR was excluded for co-linearity. When peak MELD group was included in the analysis, it was the most significant independent predictor of outcome (p \ 0.0001); however, two admission variables, total bilirubin and INRdf category, remained significant. Other variables including ABIC category and hyperammonemia were eliminated in the stepwise process when peak MELD was included. When 90 day survival was examined, hyperammonemia was no longer significant in multivariate analysis whereas DF on admission was significant. When MELD calculated with peak values during admission was included, the three significant factors were the same as at 28 days (supplementary Table E ).
Discussion
The data reported here clearly identify a subgroup of patients with alcoholic hepatitis and a significantly worse short, intermediate, and long-term prognosis. Thus 28 day, 90 day, and 6 month mortality was highest for patients with INRdf [ 50, ABIC [ 9, or MELD [ 31 on admission. These newer scoring systems identified a small fraction with a high early mortality (56-60 % at 28 days). In comparison, large randomized placebo-controlled trials of corticosteroids using DF [ 32 as a marker of poor outcome at 28 days averaged 34 % mortality without corticosteroids [21] , and mortality was 46 % among the control subjects of a randomized trial of pentoxifylline in which in-hospital deaths of 24/52 control patients occurred after 33 ± 27 days (mean ± SD) [22] . Of note, these studies enrolled patients in the last decades of the twentieth century before the changes in PT and INR measurements. INRdf is a simple calculation that increases the number of subjects identified as high risk (sensitivity) while retaining specificity (58 % mortality at 28 days) and accounting for changes in analytical reagents.
The observation that an elevated ammonia level within two days of admission was independently predictive of death within 28 days suggests it is a poor prognostic sign for patients admitted with icteric alcoholic liver disease. We used a value obtained from the electronic medical record, which may indicate that altered mentation resulted in ordering the ammonia level. Thus, a normal ammonia level precludes the possibility of hyperammonemic encephalopathy whereas elevated ammonia is consistent with a contribution of abnormal hepatic nitrogen metabolism to mental status. For ease of use, the INRdf may be preferable to the ABIC because it relies solely on addition of two numbers, one of which is not manipulated before the summation. In addition, INRdf was equivalent or superior to ABIC in most comparisons, identifying more patients with a poor prognosis at the time of admission.
Although the number of subjects with INRdf [ 50 was relatively small (33 patients, 26 not receiving steroids), the findings demonstrate that these patients have a different prognosis from those with less severe disease. When we compared our primary data for patients not receiving corticosteroids with results from previous randomized controlled trials [21] , the ranges were similar for age, bilirubin, creatinine, albumin, and AST. PT was longer, DF higher, and survival lower for the current subjects with INRdf [ 50 or ABIC [ 9 (supplementary Table F ). In contrast, for those with DF [ 32 or GAHS [ 9 mortality was similar and PT values longer than in previous studies.
Although familiar with the limitations inherent in a retrospective, single-institution study, we propose that the strengths of this report are substantial. They include the completeness of data collection, long-term follow-up of the vast majority of those with DF [ 32, and the possibility of future external validation with electronic health record data. Clinical data at PHHS, apart from discharge summaries and pathology and radiology reports, were not electronic in this period and were not extracted; consequently the cohort is potentially different from those of other studies of acute alcoholic hepatitis. In prospective studies, the acuteness of the presentation and the concurrence of symptoms and signs such as anorexia, nausea, right upper quadrant pain, tender hepatomegaly, and jaundice are used to enroll patients. None is specific when assessed alone and diagnosis relies on interpretation of clinical data. We used a bilirubin of 5 mg/ dL during admission as a surrogate for jaundice; only two patients with DF [ 32 were admitted with a bilirubin \5 mg/dL (3.1 and 3.2 mg/dL) and neither had INRdf [ 50. Of note, admission bilirubin was\2.5 mg/dL for only one patient with DF \ 32 (2.4 mg/dL) indicating that almost all the subjects were likely to be judged as jaundiced on admission. Future efforts must focus on improving the immediate outcomes for this cohort of patients and for the entire group. We have demonstrated that hospitalization with an acute decompensation of underlying chronic ALD that includes a bilirubin C5 mg/dL before discharge is a sentinel event. These are the patients for whom early liver transplantation is the one management that may prolong survival, and only if that option is not possible for psychosocial or financial reasons. Prospective interventional trials of innovative management strategies are needed urgently, particularly for patients without a transplant option, because long-term survival is possible, particularly with abstinence.
